Ramanathan Arvind, Ramanathan Arvind
Human Genetics Laboratory, Sree Balaji Medical and Dental College and Hospital, Bharath University, Narayanapuram, Pallikaranai, Chennai, Tamil Nadu, India E-mail :
Asian Pac J Cancer Prev. 2016;17(4):2297-9. doi: 10.7314/apjcp.2016.17.4.2297.
Early detection of malignant transformation with expression biomarkers has significant potential to improve the survival rate of patients as such biomarkers enable prediction of progression and assess sensitivity to chemotherapy. The expression of interferon inducible transmembrane protein 1 (IFITM1) has been associated with early invasion events in several carcinomas, including head and neck cancers, and hence has been proposed as a novel candidate biomarker. As the incidence of oral squamous cell carcinoma (OSCC) is highest in the Indian population, we sought to investigate: 1) the expression pattern of IFITM1 in OSCC tissue samples obtained from Indian patients of Dravidian origin; and 2) the possibility of using IFITM1 expression as a potential biomarker.
Total RNA extracted from thirty eight OSCC biopsy samples was subjected to semi-quantitative RT-PCR with IFITM1 and GAPDH specific primers.
Of the thirty eight OSCC samples that were analyzed, IFITM1 overexpression was identified in fifteen (39%). Seven expressed a low level, while the remainder expressed high level of IFITM1.
The overexpression of IFITM1 in OSCC samples indicates that IFITM1 may be explored for the possibility of use as a high confidence diagnostic biomarker in oral cancers. To the best of our knowledge, this is the first time that IFITM1 overexpression is being reported in Indian OSCC samples.
利用表达生物标志物早期检测恶性转化具有显著潜力,可提高患者生存率,因为此类生物标志物能够预测疾病进展并评估化疗敏感性。干扰素诱导跨膜蛋白1(IFITM1)的表达与包括头颈癌在内的多种癌症的早期侵袭事件相关,因此被提议作为一种新型候选生物标志物。由于口腔鳞状细胞癌(OSCC)在印度人群中的发病率最高,我们试图研究:1)从印度达罗毗荼裔患者获取的OSCC组织样本中IFITM1的表达模式;2)将IFITM1表达用作潜在生物标志物的可能性。
从38份OSCC活检样本中提取的总RNA,使用IFITM1和GAPDH特异性引物进行半定量逆转录聚合酶链反应。
在分析的38份OSCC样本中,15份(39%)检测到IFITM1过表达。7份表达水平低,其余表达高水平的IFITM1。
OSCC样本中IFITM1的过表达表明,IFITM1有可能被开发用作口腔癌高可信度诊断生物标志物。据我们所知,这是首次在印度OSCC样本中报道IFITM1过表达。